Entries by Evan McClure

Chie Iwaishi Joins Edwards Lifesciences as Vice President, International Regulatory & Clinical Affairs

Life Science Partner is pleased to announce the recruitment of Chie Iwaishi to Edwards Lifesciences (NYSE:EW) as Vice President, International Regulatory and Clinical Affairs, where she will lead the expansion of this Irvine-based company in the Japan and Asia-Pacific region. Iwaishi’s three decades of leadership in regulatory and clinical affairs will be an invaluable asset […]

Megan Eckerman Joins CryoLife as Vice President, Global Marketing

Life Science Partner is pleased to announce the recruitment of Megan Eckerman to CryoLife (NYSE:CRY) as Vice President of Global Marketing, where she will lead the unification of this Atlanta-based company’s US and European marketing efforts under a common worldwide strategy as CryoLife continues its transformation from an allographic human tissue provider to a global […]

Peter Schiller, PhD Joins Canary Medical as Vice President, Research & Development

Life Science Partner Executive Search is pleased to announce the recruitment of Peter Schiller, PhD to Canary Medical, where he will serve as Vice President of Research and Development. Canary Medical is an innovative medical technology company commercializing smart implants in the orthopedic, cardiovascular, and aesthetic markets. The company integrates a sensor and microprocessor system […]

Heather Creran Joins Lineagen as Chief Operating Officer

Life Science Partner has recruited Heather Creran to become the Chief Operating Officer for Lineagen, an innovative genetics diagnostics company for neurodevelopmental disorders. Creran’s depth of operational leadership experience will be a great asset for Lineagen, whose painless cheek swab test can detect hundreds of genetic conditions which can give rise to developmental delay and […]

Liz Spurgin Joins the Medical Device Innovation Consortium as Vice President, Health Economics & Patient Value

Life Science Partner is pleased to announce the recruitment of Liz Spurgin to become the first Vice President, Health Economics and Patient Value for the Medical Device Innovation Consortium (MDIC). The MDIC brings together representatives of the Food and Drug Administration (FDA), National Institutes of Health (NIH), Centers for Medicare and Medicaid Services (CMS), industry, […]

Carl Spear, OD, MBA Joins Luxottica as Senior Vice President, Eyecare

Life Science Partner is pleased to announce the recruitment of Carl Spear, OD, MBA, to serve as Senior Vice President, Eyecare for Luxottica, the world’s largest eyeware company. Luxottica is a leader in the design, manufacture and distribution of fashion, luxury, sports and performance eyewear. Of Luxottica’s 80,000 employees, more than 5,000 are US-based Doctors […]

Barbara Benedict Joins Notal Vision as Director, Patient Engagement

Life Science Partner is pleased to announce the recruitment of Barbara Benedict to Notal Vision as Director of Patient Engagement. Notal Vision is a tele-health company offering the first patient-initiated, home-based monitoring system to prevent the progression of macular degeneration through early detection and intervention. The technology combines a physical device with a data management […]

Mark Alvarez Joins Irrimax as Chief Executive Officer

Life Science Partner is pleased to announce the recruitment of Mark Alvarez to Irrimax, where he will serve as Chief Executive Officer. Irrimax is an Atlanta-based medical technology company that is redefining wound irrigation with Irrisept, the only FDA-cleared medical device for irrigation containing the proven antiseptic chlorhexidine gluconate (CHG). Alvarez was most recently Chairman, […]

Frank Stokes Joins Castle Biosciences as Chief Financial Officer

Life Science Partner is pleased to announce the recruitment of Frank Stokes to Castle Biosciences as Chief Financial Officer. Castle Biosciences is a molecular diagnostics company dedicated to helping patients and their physicians make the best possible decisions about their treatment and follow up care based on the individual molecular signature of their tumor. The […]